0000891293-15-000074.txt : 20151223
0000891293-15-000074.hdr.sgml : 20151223
20151223195632
ACCESSION NUMBER: 0000891293-15-000074
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151223
FILED AS OF DATE: 20151223
DATE AS OF CHANGE: 20151223
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CTI BIOPHARMA CORP
CENTRAL INDEX KEY: 0000891293
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911533912
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 2062827100
MAIL ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
FORMER COMPANY:
FORMER CONFORMED NAME: CELL THERAPEUTICS INC
DATE OF NAME CHANGE: 19960321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIANCO JAMES A
CENTRAL INDEX KEY: 0001198554
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12465
FILM NUMBER: 151306783
FORMER NAME:
FORMER CONFORMED NAME: BLANCO JAMES A
DATE OF NAME CHANGE: 20021015
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2015-12-23
0
0000891293
CTI BIOPHARMA CORP
ctic
0001198554
BIANCO JAMES A
3101 WESTERN AVENUE
SUITE 600
SEATTLE
WA
98121
1
1
0
0
President and CEO
Common Stock
2015-12-23
4
D
0
583217
0
D
2368302
D
Employee Stock Option (Right to Buy)
1.24
2015-12-23
4
A
0
6000000
0
A
2025-12-23
Common Stock
6000000
6000000
D
Represents the forfeiture back to CTIC of shares of restricted stock. The restricted shares were originally issued pursuant to a performance-based equity award effective as of January 3, 2012 and subsequently amended. The reporting person agreed to forfeit the restricted shares to the issuer. If a performance goal that had been applicable to such restricted stock is achieved by December 31, 2016, the reporting person will be entitled to the grant of a stock option from CTIC with respect to the same number of shares that would have been issued to the reporting person upon achievement of the goal under the original terms of the reporting person's long-term incentive award.
The option is scheduled to vest in eight semi-annual installments over the four-year period following the grant date, subject to the reporting person's continued employment or service with the issuer through the applicable vesting date.
By: Louis A. Bianco, Attorney-in-fact For: James A. Bianco
2015-12-23